This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Personalized medicine is rapidly evolving in cancer theranostics, with technology now available that allows clinicians to optimize doses of radiopharmaceuticals on an individual patient level, according to experts. And to really optimize it, you would like to be able to deliver it in a personalized manner, he said.
The use of somatostatin receptor PET imaging and therapy in meningiomas is on the rise, and new guidelines on their use can help pave the way to improved outcomes for patients, experts noted in a recent article. The article was published October 10 in the Journal of NuclearMedicine. The full article is available here.
As nuclearmedicine therapies gain stature compared to nuclearmedicine in diagnostic imaging, hospital administrators may be eyeing the potential of adding theranostics services. A shortage of nuclearmedicine technologists means a theranostics center may need to limit its patient volume.
The Society of NuclearMedicine and Molecular Imaging (SNMMI) has bestowed its Georg Charles de Hevesy Nuclear Pioneer award on Carolyn Anderson, PhD, of the University of Missouri-Columbia (MU). The award honors those who have made outstanding contributions in the field of nuclearmedicine, the SNMMI said.
With therapeutic radiopharmaceuticals coming to market quickly and available to smaller institutions around the U.S., My vision of a theranostic center includes a flagship facility that has a PET/CT scanner, a SPECT/CT scanner, and then multiple rooms for infusions of radiopharmaceuticals," Siegel explained.
He has published more than 1,000 articles, is the author or co-author of 10 textbooks, and member of editorial boards for more than 35 journals. Louis, MO A first-time Minnies finalist, Dmitry Beyder exemplifies how the role of the nuclearmedicine technologist can evolve. Dmitry Beyder.
A decade ago, only a few radiopharmaceutical agents were used to help treat cancer patients. He also helped lead the theranostics conference at the Society of NuclearMedicine and Molecular Imaging (SNMMI) 2024 midwinter meeting. However, few freestanding theranostics centers exist today. Hope added.
We hope you enjoy our article as well as the opportunity to hear directly from the recipients. Beyder played a key role in launching the radiopharmaceutical therapy (RPT) comprehensive center of excellence at WU, BJH, and Siteman Cancer Center last year. from Ukraine.
The article explores the theranostic applications of Terbium radionuclides, highlighting their diagnostic and therapeutic potential in nuclearmedicine. The post Terbium Radionuclides for Theranostic Applications in NuclearMedicine appeared first on Open MedScience.
Evans, PhD, has been named the 2024 recipient of the Society of NuclearMedicine and Molecular Imaging (SNMMI) Sam Gambhir Trailblazer Award. He has published more than 90 peer-reviewed articles and is a co-inventor on 13 patents pending or issued. He will be honored at the SNMMI's annual meeting in Toronto.
While recent evidence suggests that theranostic agents may be more effective when used earlier for prostate cancer patients, experts recommend proceeding conservatively with theranostic treatments until more is known about dose limits, according to an article published March 21 by the RSNA.
Jean-Luc Urbain, MD, PhD, has been named president-elect of the Society of NuclearMedicine and Molecular Imaging (SNMMI). Urbain, a professor of radiology and nuclearmedicine, has served in multiple roles within SNMMI, in addition to his most recent post as vice president-elect. Jean-Luc Urbain, MD, PhD. “As
Cathy Sue Cutler, PhD, has been named president of the Society of NuclearMedicine and Molecular Imaging (SNMMI). She also intends to create training and education opportunities in theranostics and to educate the public on nuclearmedicine and its value. Cathy Sue Cutler, PhD. Cutler's awards are many.
milla1cf Wed, 06/12/2024 - 21:58 June 12, 2024 — Cathy Sue Cutler, PhD, FSNMMI , chair of the Isotope Research and Production Department at Brookhaven National Laboratory in Upton, New York, has been named as president for the Society of NuclearMedicine and Molecular Imaging (SNMMI).
Urbain, MD, PhD, FASNC, professor of Radiology/NuclearMedicine and Medicine, has been named president-elect of the Society of NuclearMedicine and Molecular Imaging (SNMMI). Urbain has published about 100 journal articles and 15 book chapters and has given more than a thousand invited speaker presentations.
The major stumbling block in the clinical translation of TAT remains the development of a sturdy supply chain of these radionuclides that will match the clinical demand, IAEA scientists wrote in an article published March 11 in NuclearMedicine and Biology. The full article is available here.
We organize all of the trending information in your field so you don't have to. Join 5,000 users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content